Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Eloxx Pharmaceuticals, Inc. (ELOX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
29 Nov 2021
Geffken Daniel E.
INTERIM CFO, Officer
Eloxx Pharmaceuticals, Inc.
(ELOX)
50,000
+100%
50,000
$0.72
$36,000.00
BUY
13 May 2021
Pontifax Management 4 G.P. (2015) Ltd.
10% Owner
Eloxx Pharmaceuticals, Inc.
(ELOX)
1,791,470
+143%
5,925,925
$1.35
$7,999,999.00
BUY
13 May 2021
PAREKH RAJESH B
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
171,807
+107%
2,466,666
$1.35
$3,329,999.00
BUY
13 May 2021
Nussbaum Ran
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
1,791,470
+143%
5,925,925
$1.35
$7,999,999.00
BUY
13 May 2021
Kariv Tomer
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
1,791,470
+143%
5,925,925
$1.35
$7,999,999.00
BUY
24 Jun 2019
Pontifax Management 4 G.P. (2015) Ltd.
10% Owner
Eloxx Pharmaceuticals, Inc.
(ELOX)
510,846
+64%
200,000
$9.00
$1,800,000.00
BUY
24 Jun 2019
Nussbaum Ran
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
510,846
+64%
200,000
$9.00
$1,800,000.00
BUY
24 Jun 2019
Kariv Tomer
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
510,846
+64%
200,000
$9.00
$1,800,000.00
BUY
22 May 2018
Ward Robert
Chief Executive Officer, Director, Officer
Eloxx Pharmaceuticals, Inc.
(ELOX)
15,000
+50%
5,000
$14.34
$71,700.00
BUY
30 Apr 2018
Pontifax Management 4 G.P. (2015) Ltd.
10% Owner
Eloxx Pharmaceuticals, Inc.
(ELOX)
468,585
+295%
350,000
$9.75
$3,412,500.00
BUY
30 Apr 2018
Shabtai Gilad
10% Owner
Eloxx Pharmaceuticals, Inc.
(ELOX)
3,351,770
+2%
75,000
$9.75
$731,250.00
BUY
30 Apr 2018
Nussbaum Ran
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
468,585
+295%
350,000
$9.75
$3,412,500.00
BUY
30 Apr 2018
Kleijwegt Martijn
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
2,953,673
+11%
300,000
$9.75
$2,925,000.00
BUY
30 Apr 2018
Kariv Tomer
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
468,585
+295%
350,000
$9.75
$3,412,500.00
BUY
3 Apr 2018
Shabtai Gilad
10% Owner
Eloxx Pharmaceuticals, Inc.
(ELOX)
3,276,770
+0%
8,300
$9.46
$78,545.00
BUY
29 Mar 2018
Shabtai Gilad
10% Owner
Eloxx Pharmaceuticals, Inc.
(ELOX)
3,268,470
+0%
4,500
$9.64
$43,380.00
BUY
26 Mar 2018
Avnur Zafrira
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
2,263
+760%
2,000
$9.49
$18,980.00
BUY
23 Mar 2018
WEAVER GREGORY L
Chief Financial Officer, Officer
Eloxx Pharmaceuticals, Inc.
(ELOX)
4,500
+100%
4,500
$8.56
$38,520.00
BUY
23 Mar 2018
Ward Robert
Chief Executive Officer, Director, Officer
Eloxx Pharmaceuticals, Inc.
(ELOX)
10,000
+100%
10,000
$8.99
$89,900.00
BUY
21 Mar 2018
Pontifax Management 4 G.P. (2015) Ltd.
10% Owner
Eloxx Pharmaceuticals, Inc.
(ELOX)
384,544
+3%
12,600
$7.76
$97,830.00
BUY
21 Mar 2018
Avnur Zafrira
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
263
+100%
263
$7.60
$1,998.80
BUY
21 Mar 2018
Nussbaum Ran
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
384,544
+3%
12,600
$7.76
$97,830.00
BUY
21 Mar 2018
Kariv Tomer
Director
Eloxx Pharmaceuticals, Inc.
(ELOX)
384,544
+3%
12,600
$7.76
$97,830.00
Home